Chicago, IL (ots) - --News Direct-- VectorBuilder Inc., der er verdensførende inden for teknologi til genindgivelse, meddeler, at virksomhedens center for F&U og produktion i Guangzhou, Kina, har vundet førstepræmien på 7th “Chuangke Innovation and Entrepreneurship Global Competition”, der afholdtes i Hangzhou, Kina. Den betydningsfulde konkurrence med et meget ...
Chicago, IL (ots) - --News Direct-- Maailman johtaviin geeninsiirtoteknologiayhtiöihin lukeutuva VectorBuilder Inc. kertoo Guangzhoussa sijaitsevan tuotekehitys- ja valmistuskeskuksensa voittaneen 7. Kiinan Hangzhoussa järjestetyn Chuangke Innovation and Entrepreneurship Global Competition -innovaatiokilpailun. Tämä arvostettu ja korkeatasoinen kilpailu on Kiinan ...
Chicago, IL (ots) - --News Direct-- VectorBuilder Inc. – en global leder innen teknologier for genlevering – kunngjorde at deres FoU- og produksjonssenter i Guangzhou vant konkurransen i den syvende "Chuangke Innovation and Entrepreneurship Global Competition" som ble holdt i Hangzhou, Kina. Denne konkurransen blir ansett å være meget innflytelsesrik og og er en av de største i Kina. Den dekker bedrifter i vekst ...
Chicago, IL (ots) - --News Direct-- VectorBuilder Inc. - en global ledare inom genleveransteknik - meddelade att deras FoU- och tillverkningscenter i Guangzhou vann mästerskapet i sjunde globala tävlingen i innovation och företagande, som hölls i "Chuangke" Hangzhou, Kina. Denna inflytelserika och mycket konkurrensdrivna tävling är en av de största i Kina och täcker företag i tillväxtstadiet inom alla ...
Chicago, IL (ots) - --News Direct-- VectorBuilder Inc. – a global leader in gene delivery technologies – announced that its R&D and manufacturing center in Guangzhou won championship in the 7th “Chuangke Innovation and Entrepreneurship Global Competition” held in Hangzhou, China. This influential and highly competitive contest is one of the largest in China, covering growth-stage enterprises across all high-tech ...
Chicago, IL (ots) - VectorBuilder Inc. – a global leader in gene delivery technologies – recently announced the completion of $57 million funding, which was co-led by Legend Capital. The fund will support the construction of VectorBuilder’s new Gene Delivery Research and Manufacturing Campus, and further boost the company’s R&D capabilities and global business presence. VectorBuilder was initially established in ...